Track the Diaceutics PLC share price and the full management transaction log of the company, a listed issuer based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). Market capitalisation: €126.1m. The latest transaction was reported on 7 March 2024 (Purchase). Among the most active insiders: Graham Patterson. All data is free.
Analysts rate Diaceutics PLC Strong Buy (bullish), based on 5 analysts. Average price target: £213.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Diaceutics PLC es una empresa especializada en el análisis de datos de salud, con el objetivo de mejorar los resultados de los pacientes a través de tratamientos personalizados. Opera principalmente en el mercado del Reino Unido y se centra en la optimización de las pruebas de diagnóstico.